Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.
about
Involvement of autophagy in ovarian cancer: a working hypothesisEMT-Inducing Molecular Factors in Gynecological CancersMicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancerPrediction of chemo-response in serous ovarian cancerThe temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples.Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients.The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cellsPotential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer.CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling.Immediate early response gene X-1, a potential prognostic biomarker in cancersComparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.LC-MS Based Sphingolipidomic Study on A2780 Human Ovarian Cancer Cell Line and its Taxol-resistant Strain.Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth.Monoclonal antibodies therapies for ovarian cancer.Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells.Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer.Differential cellular responses induced by dorsomorphin and LDN-193189 in chemotherapy-sensitive and chemotherapy-resistant human epithelial ovarian cancer cells.Shikonin induces mitochondria-mediated apoptosis and attenuates epithelial-mesenchymal transition in cisplatin-resistant human ovarian cancer cells.
P2860
Q21198790-E9CBBDDA-5B9F-4A62-9D23-C8C618F9DE80Q26781912-DB365038-A2AB-4F2C-BFE5-996E9E4CABA3Q26822743-4D4C1A2F-FF82-4F29-94A9-98FFB29C0244Q29248636-B9ADD21A-F1C0-4209-A721-293A078F739DQ33574500-65B3EEAE-E7DF-4938-859F-8A49658D5873Q33671544-7AE7F029-9CFB-4AE9-81A7-2EA2724B111DQ34552289-0E336F6B-5594-4956-872E-553E9BB4AD12Q34833628-F063CB1F-2552-4B40-9DF2-0C66E508AB1EQ35067887-748AE35A-47E3-41DD-AF8E-ACE6BE38D2F5Q35240656-D8C1F294-5843-4E02-891B-6E2531796C35Q36940496-0D5C1737-758C-4AAA-8EAB-605840E5DE66Q37310661-AAD1F0B2-501B-466B-BA9D-0F1624024065Q37430771-C4EB82B5-EBF9-43B2-9664-7EB47AA21801Q38078400-F998F9D9-B22A-48B7-BD58-7FAEA41AE4ECQ38524502-7F17D1A0-1D2E-4F64-AE8D-B5D6F4E096C1Q38703674-CCB3A5AB-3380-4829-96FB-4E8B9D6AAC6BQ39638414-9F1C1984-338C-4E9F-9816-D9F07516DF97Q46837899-F26E6ECC-8453-43AF-B3ED-479FAC263533Q52725086-02F16DD5-01DD-49AB-A95A-BCB4A0CA084E
P2860
Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Optimizing molecular-targeted ...... s and cell signaling pathways.
@ast
Optimizing molecular-targeted ...... s and cell signaling pathways.
@en
type
label
Optimizing molecular-targeted ...... s and cell signaling pathways.
@ast
Optimizing molecular-targeted ...... s and cell signaling pathways.
@en
prefLabel
Optimizing molecular-targeted ...... s and cell signaling pathways.
@ast
Optimizing molecular-targeted ...... s and cell signaling pathways.
@en
P2860
P356
P1433
P1476
Optimizing molecular-targeted ...... s and cell signaling pathways.
@en
P2093
Donavon Hiss
P2860
P304
P356
10.1155/2012/737981
P577
2012-02-06T00:00:00Z